NORTH AMERICA NEUROSTIMULATION DEVICE MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • NORTH AMERICA NEUROSTIMULATION DEVICE MARKET FORECAST 2019-2027

NORTH AMERICA NEUROSTIMULATION DEVICE MARKET FORECAST 2019-2027

Neurostimulator devices function either by stimulating nerve impulses or by inhibiting pain signals at target sites such as the central nervous system, autonomic nervous system, the peripheral nervous system and the deep nuclei of the brain. A growing base of geriatric population triggering the incidence rates of target disorders will be attributed to the market growth in North America. 

NORTH AMERICA NEUROSTIMULATION DEVICE MARKET FORECAST 2019-2027

North America Neurostimulation Device Market by System (Spinal Cord Stimulators (Scs), Deep Brain Stimulators (Dbs), Sacral Nerve Stimulators (Sns), Vagus Nerve Stimulators (Vns), Gastric Electric Stimulator, Other System) by Applications (Pain Management, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Other Applications) by Geography.

Request free sample

Neurostimulator devices function either by stimulating nerve impulses or by inhibiting pain signals at target sites such as the central nervous system, autonomic nervous system, the peripheral nervous system and the deep nuclei of the brain. A growing base of geriatric population triggering the incidence rates of target disorders will be attributed to the market growth in North America. The market is expected to propel at a CAGR of 9.73% during the forecasted years 2019-2027.

The increasing demand for neurostimulation devices which can withstand MRI scans is expected to provide more opportunity for market growth in the region. Millions of people suffer from acute or chronic pain each year in the US. It is a major burden on the region’s healthcare system affecting rehabilitation and reducing productivity. This is expected to profit the market. The US was the largest revenue contributor to this region in 2018 because of the increased use of neurostimulation devices for various diseases. Advances in technology and the availability of reimbursement by Medicare propel market growth in the country will be responsible for the market development in future.

Major market players in the region are Cogentix Medical Inc., St. Jude Medical Inc. (acquired by Abbott Laboratories), Aleva Neurotherapeutics SA, Boston Scientific Corporation, Helius Medical Technologies, The Magstim Company Limited, Cyberonics Inc., Neuronetics Inc., Depuy Synthes Companies, Ekso Bionics Holding Inc., Medtronic PLC, Dr. Langer Medical GmBH, Ectron Limited, Nevro Corp. and Hocoma AG.

 

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • SPINAL CORD STIMULATORS HOLDS THE LARGEST MARKET SHARE IN TERMS OF NEUROSTIMULATION SYSTEM
      • PAIN MANAGEMENT IS THE MAJORLY USED NEUROSTIMULATION APPLICATION
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • HIGH OCCURRENCE OF NEURO DISEASES
      • DEVELOPMENTS IN TECHNOLOGY
      • RISING DEMAND FOR MINIMALLY INVASIVE SURGERIES
      • HIGH MARKET POTENTIAL FOR SCS DEVICES IN NEUROSTIMULATION
      • INCREASING GERIATRIC POPULATION
      • FAVORABLE REIMBURSEMENT AND INSURANCE APPROVAL POLICIES
    • MARKET RESTRAINTS
      • HIGH PRICE OF NEUROMODULATION TREATMENT
      • SIDE EFFECTS OF ASSOCIATED NEUROSTIMULATION DEVICES
      • ANONYMOUS APPLIANCE OF SCS THERAPY
      • STRINGENT REGULATORY APPROVALS
    • MARKET OPPORTUNITIES
      • DEVELOPMENT OF INDICATION FOR SCS
      • INCREASING THE DEMAND FOR NEUROSTIMULATION DEVICES WITHSTANDING MRI SCANS
      • GROWING OCCURRENCE OF CHRONIC DISCOMFORT
    • MARKET CHALLENGES
      • OBTAINABILITY OF ALTERNATIVE THERAPY
      • SAFETY CONCERNS
  1. MARKET BY SYSTEM
    • SPINAL CORD STIMULATORS (SCS)
    • DEEP BRAIN STIMULATORS (DBS)
    • SACRAL NERVE STIMULATORS (SNS)
    • VAGUS NERVE STIMULATORS (VNS)
    • GASTRIC ELECTRIC STIMULATOR
    • OTHER SYSTEM
  2. MARKET BY APPLICATIONS
    • PAIN MANAGEMENT
    • EPILEPSY
    • ESSENTIAL TREMOR
    • URINARY AND FECAL INCONTINENCE
    • DEPRESSION
    • DYSTONIA
    • GASTROPARESIS
    • PARKINSON’S DISEASE
    • OTHER APPLICATIONS
  3. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTES
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • THREAT OF RIVALRY
    • ESTIMATION ANALYSIS
      • INCREASING PREVALENCE OF MENTAL HEALTH PROBLEMS
      • RISING HEALTHCARE EXPENDITURE ACROSS THE GLOBE
      • RISING GERIATRIC POPULATION
    • VALUE CHAIN ANALYSIS
    • PESTLE ANALYSIS
    • OPPORTUNITY MATRIX
  4. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
    • COMPANY PROFILES
      • ALEVA NEUROTHERAPEUTICS SA
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • BOSTON SCIENTIFIC CORPORATION
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • COGENTIX MEDICAL INC
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • CYBERONICS INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • DEPUY SYNTHES COMPANIES
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • LANGER MEDICAL GMBH
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • ECTRON LIMITED
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • EKSO BIONICS HOLDING INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • HELIUS MEDICAL TECHNOLOGIES
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • HOCOMA AG
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • MEDTRONIC PLC
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • NEURONETICS INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • NEVRO CORP
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • JUDE MEDICAL INC. (ACQUIRED BY ABBOTT LABORATORIES)
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • THE MAGSTIM COMPANY LIMITED
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES

LIST OF TABLES

TABLE  1       NORTH AMERICA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

TABLE  2       NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY SYSTEM 2019-2027 ($ MILLION)

TABLE  3       NORTH AMERICA SPINAL CORD STIMULATORS MARKET 2019-2027 ($ MILLION)

TABLE  4       NORTH AMERICA DEEP BRAIN STIMULATORS MARKET 2019-2027 ($ MILLION)

TABLE  5       NORTH AMERICA SACRAL NERVE STIMULATORS MARKET 2019-2027 ($ MILLION)

TABLE  6       NORTH AMERICA VAGUS NERVE STIMULATORS MARKET 2019-2027 ($ MILLION)

TABLE  7       NORTH AMERICA GASTRIC ELECTRIC STIMULATOR MARKET 2019-2027 ($ MILLION)

TABLE  8       NORTH AMERICA OTHER SYSTEM MARKET 2019-2027 ($ MILLION)

TABLE  9       NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS 2019-2027 ($ MILLION)

TABLE  10     NORTH AMERICA PAIN MANAGEMENT MARKET 2019-2027 ($ MILLION)

TABLE  11     NORTH AMERICA EPILEPSY MARKET 2019-2027 ($ MILLION)

TABLE  12     NORTH AMERICA ESSENTIAL TREMOR MARKET 2019-2027 ($ MILLION)

TABLE  13     NORTH AMERICA URINARY AND FECAL INCONTINENCE  MARKET 2019-2027 ($ MILLION)

TABLE  14     NORTH AMERICA DEPRESSION MARKET 2019-2027 ($ MILLION)

TABLE  15     NORTH AMERICA DYSTONIA  MARKET 2019-2027 ($ MILLION)

TABLE  16     NORTH AMERICA GASTROPARESIS MARKET 2019-2027 ($ MILLION)

TABLE  17     NORTH AMERICA PARKINSON’S DISEASE MARKET 2019-2027 ($ MILLION)

TABLE  18     NORTH AMERICA OTHER APPLICATIONS MARKET 2019-2027 ($ MILLION)

TABLE  19     NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY GEOGRAPHY 2019-2027, (IN $ BILLION)

TABLE  20     CONDITION TREATED BY NEUROSTIMULATION DEVICES IN THE UNITED STATES

TABLE  21     NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)

LIST OF FIGURES

FIGURE  1     NORTH AMERICA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE  2     NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SHARE BY SYSTEM 2018 & 2027 (%)

FIGURE  3     NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY SPINAL CORD STIMULATORS 2019-2027 ($ MILLION)

FIGURE  4     NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY DEEP BRAIN STIMULATORS 2019-2027 ($ MILLION)

FIGURE  5     NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY SACRAL NERVE STIMULATORS 2019-2027 ($ MILLION)

FIGURE  6     NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY VAGUS NERVE STIMULATORS 2019-2027 ($ MILLION)

FIGURE  7     NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY GASTRIC ELECTRIC STIMULATOR 2019-2027 ($ MILLION)

FIGURE  8     NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY OTHER SYSTEM 2019-2027 ($ MILLION)

FIGURE  9     NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SHARE BY APPLICATIONS 2018 & 2027 (%)

FIGURE  10  NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY PAIN MANAGEMENT 2019-2027 ($ MILLION)

FIGURE  11  NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY EPILEPSY  2019-2027 ($ MILLION)

FIGURE  12  NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY ESSENTIAL TREMOR 2019-2027 ($ MILLION)

FIGURE  13  NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY URINARY AND FECAL INCONTINENCE  2019-2027 ($ MILLION)

FIGURE  14  NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY DEPRESSION 2019-2027 ($ MILLION)

FIGURE  15  NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY DYSTONIA  2019-2027 ($ MILLION)

FIGURE  16  NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY GASTROPARESIS 2019-2027 ($ MILLION)

FIGURE  17  NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY PARKINSON’S DISEASE 2019-2027 ($ MILLION)

FIGURE  18  NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)

FIGURE  19  PORTER’S FIVE FORCE MODEL

FIGURE  22  VALUE CHAIN OF NEUROSTIMULATION DRUGS

FIGURE  23  THE UNITED STATES NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE  24  CANADA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE  25  NEUROSTIMULATION DEVICE COMPANY MARKET SHARE 2018 (% )

  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. MARKET BY SYSTEM
    • SPINAL CORD STIMULATORS (SCS)
    • DEEP BRAIN STIMULATORS (DBS)
    • SACRAL NERVE STIMULATORS (SNS)
    • VAGUS NERVE STIMULATORS (VNS)
    • GASTRIC ELECTRIC STIMULATOR
    • OTHER SYSTEM
  2. MARKET BY APPLICATIONS
    • PAIN MANAGEMENT
    • EPILEPSY
    • ESSENTIAL TREMOR
    • URINARY AND FECAL INCONTINENCE
    • DEPRESSION
    • DYSTONIA
    • GASTROPARESIS
    • PARKINSON’S DISEASE
    • OTHER APPLICATIONS

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now